International Journal of Medicinal Mushrooms

ISSN for PRINT: 1521-9437

For Online Access

Best Paper Award Selection - Editorial Board Site

2006, Volume8

Issue 4

108 pages

DOI: 10.1615/IntJMedMushr.v8.i4

Issue price - $138.00

Girish Tidke
Department of Biotechnology, Amravati Univarsity, Amravati, Maharashtra - 444602, Iindia

Mahendra K. Rai
Department of Biotechnology, Amravati University, Amravati, Maharashtra-444 602, India

Mushrooms are a new and emerging source of potent pharmaceutical products. Medicinal mushrooms are being used in countries such as China, Japan, Korea, India, and also Russia, and now Western countries have also realized the curative properties of mushrooms. Ganoderma lucidum, Lentinus edodes, Trametes versicolor, Schizophyllum commune, Flammulina velutipes, Pleurotus ostreatus, Agaricus bisporus, A. brasiliensis Pholiota nameko, Tricholoma matsutake, Auricularia auricula, and Grifola frondosa possess wide range of bioactivities, e.g., anticancerous, antibacterial, antiviral, antifungal, antidiabitic, and anti-inflammatory. These are also used in cardiovascular disorders. Usually, mushrooms are administered orally or intraperitoneally. Mushrooms are also used for the production of dyes. These include Agaricus spp., Coriolopsis spp., Daedalea sterioides, Ganoderma applanatum, G. curtissi, G. spruci, G. resupinacium, Hexagonia hirta, H. tenicis, Laetiporus sulphureus, Lenzites betulina, Lycoperdon imbricatum, Oxiporus corticola, Phaeolus schwenitzi, Polyporus alveolus, P. brumalis, and Schizopora spp. There is a need to screen these mushrooms for their bioactivity and also for dye production. The present review aims to discuss the therapeutic activity and dye-producing properties of mushrooms.

DOI: 10.1615/IntJMedMushr.v8.i4.60 Download article, 351-360 pages

Article price - $35.00

<< Previous article   Next article >>